[{"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0960-2020", "product_description": "Polyoxyl Lauryl Ether (Polidocanol) Injection, LAURETH-9 (POLIDOCANOL) 5% INJECTABLE, For IV Use, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-060-3", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 10152019+53126, Exp 4/6/2020"}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0937-2020", "product_description": "Alprostadil/Papaverine Hydrochloride/Phentolamine Mesylate Injection  20MCG/30MG/1MG/ML Injectable, For Intracavernosal Use, Freeze, 2.5 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0545-2", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 11112019+53210, Exp 4/4/2020"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84516", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Natiowide", "recall_number": "D-0643-2020", "product_description": "Glenmark Ranitidine Tablets USP 300 mg Rx Only 250 Tablets Manufactured by: Glenmark Pharmaceuticals Ltd. Colvale-Bandez, Goa 403513, India Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ   NDC 68462-249-20", "product_quantity": "500,960 bottles", "reason_for_recall": "CGMP Deviations: Presence of NDMA impurity detected in product.", "recall_initiation_date": "20191217", "center_classification_date": "20200105", "report_date": "20200115", "code_info": "7701069A  7701070A  7701084A  7701085A  7701087A  7701094A  7701095A  7701140A  7701141A  7701142A  7701157A  7701162A  7701182A  7701217A  7701218A  7701219A  7701236A  7701237A  7701220A  7701456A  7701470A  7701520A  7701671A  7701696A  7701697A  7701698A  7701797A  7701928A  7701929A  7701942A  7701943A  7702065A  7702066A  7702067A  7702095A  7702096A  7702097A  7702098A  7702188A  7702189A  7702190A  7702196A  7702197A  7702198A  7702199A  7702348A  7702338A  7702347A  7702349A  7702350A  7702391A  7702392A  7702546A  7702547A  7702548A  7702616A  7702617A  7702618A  7702619A  7702620A  7702763A  7702764A  7702851A  7702852A  7702853A  7702854A  7702855A  7702868A  7702869A  7702870A  7702871A  7702920A  7703054A  7703055A  7703056A  7703057A  7703058A  7703206A  7703208A  7703454A  7703455A  7703456A  7703486A  7703487A  7703488A  7703489A  7703490A  7703945A  7703946A  7703947A  7704111A  7704112A  7704113A  7704234A  7704235A  7704236A  7704237A  7704285A  7704286A  7704287A  7704288A  7704370A  7704371A  7704428A  7704429A  7704430A  7704431A  7704814A  7704838A  7704839A  7704840A  7704935A  7704936A  7704992A  7704996A  7704997A  7704998A  7704999A  7705037A  7705298A  7705299A  7705300A  7705301A  7705302A  7705303A  7705546A  7705584A  7705544A  7705545A  7705572A  7705585A  19190456  19190472  19190490  19191934  19191942  19191959  19192504"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0749-2020", "product_description": "LIPO B 25MG/50MG/50MG/1000MCG/ML  (10ML VIAL) in 20 mL syringe and 10 mL vial Assurance Infusion (713) 533-8800", "product_quantity": "2 syringes/1 vial", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 09172019@18 Exp. 03/15/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0943-2020", "product_description": "BETAMETHASONE ACETATE/BETAMETHASONE (PF) Injectable Suspension, Betamethasone Acetate/Betamethasone (PF) CMC [10ML] 7MG/ML INJ SUSP, For IM, IA Use, Shake Well, 10 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0621-1", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 07092019+52610, Exp 2/6/2020; 07232019+52734, Exp 2/19/2020; 08282019+52853, 09042019+52878, 09102019+52903, Exp 3/2/2020; 09182019+52929, Exp 4/17/2020; 10092019+53082, Exp 2/28/2020, 10152019+53124; Exp 5/4/2020; 10222019+53142, Exp 2/28/2020; 10292019+53160, 11052019+53186, Exp 5/4/2020; 11202019+53257, Exp 6/19/2020; 11212019+53270, Exp 6/20/2020; 12042019+53317, Exp 7/3/2020; 12102019+53363, Exp 7/9/2020"}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0971-2020", "product_description": "Methylprednisolone Acetate Injectable Suspension, METHYLPREDNISOLONE ACETATE [10ML] CMC 100 MG/ML INJ SUSP, For IM, IA Use, Shake Well, 10 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0619-1", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 06122019+52423, Exp 7/9/2020; 06122019+52420, Exp 7/9/2020; 07182019+52703, Exp 8/14/2020"}, {"status": "Terminated", "city": "Hauppauge", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M013"], "brand_name": ["ACETAMINOPHEN"], "generic_name": ["ACETAMINOPHEN"], "manufacturer_name": ["Major Pharmaceuticals"], "product_ndc": ["0904-6730"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["ACETAMINOPHEN"], "rxcui": ["198440"], "spl_id": ["17f3b749-01e8-2561-e063-6294a90a5d3b"], "spl_set_id": ["76cb8209-6c43-322e-e053-2991aa0a51eb"], "package_ndc": ["0904-6730-60", "0904-6730-80", "0904-6730-59", "0904-6730-61"], "is_original_packager": [true], "upc": ["0309046730804", "309046730606", "309046730804"], "unii": ["362O9ITL9D"]}, "product_type": "Drugs", "event_id": "84857", "recalling_firm": "Contract Pharmacal Corporation", "address_1": "135 Adams Ave", "address_2": "", "postal_code": "11788-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0858-2020", "product_description": "Major Extra Strength Acetaminophen Tablets, 500 mg Pain Reliever/Fever Reducer, packaged in a) 100-count bottles (NDC 0904-6730-60; UPC 3 09046 73060 6) and b) 1000-count bottles (NDC 0904-6730-80; UPC 3 09046 73080 4) Distributed by Major Pharmaceuticals 17177 N. Laurel Park Drive, Suite 233 Livonia, MI 45162 USA", "product_quantity": "a) 1176 bottles b) 6,216 bottles", "reason_for_recall": "Presence of Foreign Tablets/Capsules: Complaint involving one Women's Prenatal dietary supplement tablet commingled in a bottle of Extra Strength Acetaminophen 500 mg contents 1000 count bottle.", "recall_initiation_date": "20200203", "center_classification_date": "20200227", "termination_date": "20240422", "report_date": "20200219", "code_info": "Lot #: 193005, Exp. Date 08/21", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0666-2020", "product_description": "BAC 160MCG/HYDROM 16MG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12112019@20 Exp. 12/20/2019", "more_code_info": ""}, {"country": "United States", "city": "Pulaski", "address_1": "615 N 1st St", "reason_for_recall": "Failed Impurities/Degradation Specifications: High out of specification results for related compounds.", "address_2": "", "product_quantity": "3,989 cartons", "code_info": "Lots: 25246, Exp. 02/2021; 24532, Exp. 10/2020; 23647, Exp. 06/2020", "center_classification_date": "20200113", "distribution_pattern": "Nationwide in the USA.", "state": "TN", "product_description": "Dutasteride Capsules, 0.5 mg, 30 Capsules (6 X 5) Unit Dose per carton, Rx Only, Manufactured for: AvKARE, Inc., Pulaski, TN 38478, NDC 50268-282-13.", "report_date": "20200122", "classification": "Class II", "openfda": {}, "recalling_firm": "AVKARE Inc.", "recall_number": "D-0661-2020", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "84677", "termination_date": "20210714", "more_code_info": "", "recall_initiation_date": "20200107", "postal_code": "38478-2403", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84527", "recalling_firm": "MPRX, Inc. dba Medical Park Pharmacy", "address_1": "8230 Elmbrook Dr Ste 600b", "address_2": "N/A", "postal_code": "75247-4144", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "TX", "recall_number": "D-0816-2020", "product_description": "Squaric Acid 0.1% Topical Solution (Clinic) 30 mL", "product_quantity": "1 bottle", "reason_for_recall": "Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.", "recall_initiation_date": "20191218", "center_classification_date": "20200129", "termination_date": "20221213", "report_date": "20200205", "code_info": "Lot: 61380:42 Use by: 05/04/2020"}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84527", "recalling_firm": "MPRX, Inc. dba Medical Park Pharmacy", "address_1": "8230 Elmbrook Dr Ste 600b", "address_2": "N/A", "postal_code": "75247-4144", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "TX", "recall_number": "D-0811-2020", "product_description": "Progesterone 200 mg Troche", "product_quantity": "1 bottle", "reason_for_recall": "Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.", "recall_initiation_date": "20191218", "center_classification_date": "20200129", "termination_date": "20221213", "report_date": "20200205", "code_info": "Lot: 61242:26 Use by: 02/28/2020"}, {"status": "Terminated", "city": "Greenville", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203621"], "brand_name": ["NYSTATIN"], "generic_name": ["NYSTATIN"], "manufacturer_name": ["Pharmaceutical Associates, Inc."], "product_ndc": ["0121-0810", "0121-4810"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["NYSTATIN"], "rxcui": ["312055"], "spl_id": ["d57cde69-0eb9-180d-e053-2995a90a33aa"], "spl_set_id": ["31e3da10-5a7b-4bc5-8a4f-3e786b64c13a"], "package_ndc": ["0121-0810-02", "0121-0810-16", "0121-4810-05", "0121-4810-40", "0121-4810-00", "0121-4810-50"], "is_original_packager": [true], "upc": ["0301210810022"], "nui": ["N0000175498", "M0017172"], "pharm_class_epc": ["Polyene Antifungal [EPC]"], "pharm_class_cs": ["Polyenes [CS]"], "unii": ["BDF1O1C72E"]}, "product_type": "Drugs", "event_id": "84712", "recalling_firm": "Pharmaceutical Associates Inc", "address_1": "1700 Perimeter Rd", "address_2": "N/A", "postal_code": "29605-5252", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the US", "recall_number": "D-0824-2020", "product_description": "Nystatin Oral Suspension, USP 100,000 units per mL Cherry/Peppermint Flavor, 16 fl oz (473 mL)  Rx Only, pai, Pharmaceutical Associates, Inc. Greenville, SC 29605. NDC 0121-0810-16", "product_quantity": "6288  16 oz bottles", "reason_for_recall": "Subpotent: Out of specification for assay at the 12-month time point.", "recall_initiation_date": "20200114", "center_classification_date": "20200203", "termination_date": "20210603", "report_date": "20200205", "code_info": "Lots: BB70, BB71 Exp. May 2020"}, {"country": "United States", "city": "Miami", "address_1": "7715 NW 64th St", "reason_for_recall": "Microbial Contamination of Non-Sterile Products", "address_2": "", "product_quantity": "4080 8 FL Oz bottles", "code_info": "Lot: 19B42 Exp. February 2022", "center_classification_date": "20200214", "distribution_pattern": "Distributed Nationwide in the USA", "state": "FL", "product_description": "New! Rompe Pecho MAX Multi Symptoms, 8 FL. Oz (237 mL) bottle, Distributed by: Efficient Laboratories, Inc. Miami, FL 33166. UPC 0 00856 00309 5", "report_date": "20200219", "classification": "Class II", "openfda": {}, "recalling_firm": "Efficient Laboratories, Inc.", "recall_number": "D-0847-2020", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "84864", "termination_date": "20201022", "more_code_info": "", "recall_initiation_date": "20200131", "postal_code": "33166-2719", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Brampton", "state": "", "country": "Canada", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "84678", "recalling_firm": "Sigan Industries Inc.", "address_1": "296 Orenda Rd", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "IL", "recall_number": "D-0782-2020", "product_description": "Eczema Skin Relief Lotion, 2% Colloidal Oatmeal Skin Protectant Lotion, NET WT 14 OZ (396 g), NDC 65365-266-01, Distributed by: CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895.", "product_quantity": "11,004 bottles", "reason_for_recall": "Microbial contamination of non-sterile product.", "recall_initiation_date": "20200107", "center_classification_date": "20200116", "termination_date": "20220812", "report_date": "20200122", "code_info": "Lot#: 2508-08-337, 2538-08-337, Exp 8/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0981-2020", "product_description": "Selenium Injection, SELENIUM  200MCG/ML INJECTABLE, For IV Use, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0227-3", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 11052019+53182, Exp 4/7/2020"}, {"status": "Terminated", "city": "Hawthorne", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA078525"], "brand_name": ["LAMOTRIGINE"], "generic_name": ["LAMOTRIGINE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["51672-4130", "51672-4131", "51672-4132", "51672-4133"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LAMOTRIGINE"], "rxcui": ["198427", "198428", "198429", "282401"], "spl_id": ["4148a175-3297-0339-e063-6294a90a2ffb"], "spl_set_id": ["b829f9b2-f0ac-408a-a6f4-18b72150227d"], "package_ndc": ["51672-4130-6", "51672-4130-4", "51672-4130-1", "51672-4130-3", "51672-4130-0", "51672-4131-6", "51672-4131-4", "51672-4131-1", "51672-4131-3", "51672-4131-0", "51672-4132-6", "51672-4132-4", "51672-4132-1", "51672-4132-2", "51672-4132-3", "51672-4132-0", "51672-4133-6", "51672-4133-4", "51672-4133-1", "51672-4133-2", "51672-4133-3", "51672-4133-0"], "is_original_packager": [true], "upc": ["0351672413019", "0351672413347", "0351672413248", "0351672413118"], "nui": ["N0000175753", "N0000008486", "N0000175751", "N0000187061", "N0000000191"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]", "Mood Stabilizer [EPC]"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Organic Cation Transporter 2 Inhibitors [MoA]", "Dihydrofolate Reductase Inhibitors [MoA]"], "unii": ["U3H27498KS"]}, "product_type": "Drugs", "event_id": "84645", "recalling_firm": "Taro Pharmaceuticals U.S.A., Inc.", "address_1": "3 Skyline Dr", "address_2": "", "postal_code": "10532-2174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S. and Puerto Rico.", "recall_number": "D-0833-2020", "product_description": "Lamotrigine Tablets, USP, 100 mg, Rx Only, 100-count bottle,  Mfd. by: Taro Pharmaceutical Industries Ltd. Haifa Bay, Israel 2624761 Dist. by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532, NDC 51672-4131-1.", "product_quantity": "", "reason_for_recall": "Cross Contamination; Lamotrigine Tablets 100 mg USP was contaminated with enalapril maleate.", "recall_initiation_date": "20191220", "center_classification_date": "20200207", "termination_date": "20240223", "report_date": "20200219", "code_info": "Lot #: 331771, Exp. June 2021", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0680-2020", "product_description": "BUP 10MG/ FENT 1000MCG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12162019@29 Exp. 12/25/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206763"], "brand_name": ["OLMESARTAN MEDOXOMIL"], "generic_name": ["OLMESARTAN MEDOXOMIL"], "manufacturer_name": ["Ascend Laboratories, LLC"], "product_ndc": ["67877-445", "67877-446", "67877-447"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["OLMESARTAN MEDOXOMIL"], "rxcui": ["349373", "349401", "349405"], "spl_id": ["a1d66aa9-d0fa-4d21-bba0-ff8078c2e5af"], "spl_set_id": ["142b735a-e1cd-46e1-a523-3ef061001bf9"], "package_ndc": ["67877-445-30", "67877-445-90", "67877-445-05", "67877-445-10", "67877-446-30", "67877-446-90", "67877-446-05", "67877-446-10", "67877-446-33", "67877-446-84", "67877-446-74", "67877-446-38", "67877-447-30", "67877-447-90", "67877-447-05", "67877-447-10"], "is_original_packager": [true], "upc": ["0367877445304"], "unii": ["6M97XTV3HD"]}, "product_type": "Drugs", "event_id": "84818", "recalling_firm": "Ascend Laboratories LLC", "address_1": "339 Jefferson Rd Ste 101", "address_2": "N/A", "postal_code": "07054-3707", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-0828-2020", "product_description": "Olmesartan Medoxomil Tablets 20 mg, Rx Only, 90 Tablets per Bottle, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013 INDIA, Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054, NDC 67877-446-90.", "product_quantity": "192 Bottles", "reason_for_recall": "cGMP Deviations; Olmesartan Medoximil Tablets 20 mg was released in error with alternate API source prior to filing and approval of Prior Approval Supplement.", "recall_initiation_date": "20200124", "center_classification_date": "20200206", "termination_date": "20211029", "report_date": "20200212", "code_info": "Lot #: 19122552, Exp 7/31/2021"}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0940-2020", "product_description": "AscorbiX (Buffered C) Injection, Ascorbix (50ML) 500MG/ML Injectable, For IV, IM, SC Use, Refrigerate, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0226-5", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 08222019+52828, Exp 2/28/2020; 09092019+52889, Exp 3/17/2020; 09182019+52924, Exp 3/26/2020; 09262019+52971, Exp 4/3/2020; 10142019+53108, Exp 4/21/2020; 10212019+53136, Exp 4/28/2020; 10302019+53164, Exp 5/7/2020; 11252019+53278, Exp 6/2/2020; 11262019+53284, Exp 6/3/2020"}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206028"], "brand_name": ["MEMANTINE HYDROCHLORIDE"], "generic_name": ["MEMANTINE HYDROCHLORIDE"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-246", "68180-249", "68180-247", "68180-248"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["MEMANTINE HYDROCHLORIDE"], "rxcui": ["996594", "996603", "996609", "996615"], "spl_id": ["e7dc37e2-b1d1-4abf-89a4-6cffd5392597"], "spl_set_id": ["24290655-47f3-4042-a977-a832c5161d2c"], "package_ndc": ["68180-246-06", "68180-249-06", "68180-249-09", "68180-249-02", "68180-247-06", "68180-247-09", "68180-248-06"], "is_original_packager": [true], "unii": ["JY0WD0UA60"]}, "product_type": "Drugs", "event_id": "84948", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "Harborplace Tower", "address_2": "111 S Calvert St Fl 21st", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States.", "recall_number": "D-0855-2020", "product_description": "Memantine Hydrochloride Extended Release Capsules, 21 mg, 30-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 United States. Manufactured by: Lupin Limited Pithampur (M.P.)-454 775, INDIA, NDC 68180-248-06", "product_quantity": "6,294 bottles", "reason_for_recall": "Failed Dissolution Specifications: Low out of specification results observed in dissolution test at six-month long-term stability study.", "recall_initiation_date": "20200212", "center_classification_date": "20200224", "termination_date": "20210603", "report_date": "20200219", "code_info": "Lot #: H900330, exp. date 11/2020.", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0743-2020", "product_description": "HYDROMORPHONE 2MG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "4 syringes", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lots: 12112019@1 Exp. 12/20/2019; 12112019@6 Exp. 12/20/2019; 12162019@23 Exp. 12/25/2019; 12172019@7 Exp. 12/26/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0739-2020", "product_description": "HYDROM 1MG/MORP 20MG/SUF 100MCG/ML  INJ in 20 mL syringe Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12162019@3 Exp. 12/25/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Salt Lake City", "state": "UT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83757", "recalling_firm": "Tuscano and Delucia Group (DBA Entropic Labs)", "address_1": "2150 S West Temple Apt 413", "address_2": "", "postal_code": "84115", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0800-2020", "product_description": "Entropic Labs SARM RAD-140, 20mg Capsules, 30-count bottles, Entropic Labs UPC#: 651074545302", "product_quantity": "60", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: product  contains Selective Androgen Receptor Modulators (SARMs)", "recall_initiation_date": "20190824", "center_classification_date": "20200122", "termination_date": "20230712", "report_date": "20200129", "code_info": "All lots", "more_code_info": ""}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84527", "recalling_firm": "MPRX, Inc. dba Medical Park Pharmacy", "address_1": "8230 Elmbrook Dr Ste 600b", "address_2": "N/A", "postal_code": "75247-4144", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "TX", "recall_number": "D-0819-2020", "product_description": "Tadalafil 6 mg Capsule", "product_quantity": "7 bottles", "reason_for_recall": "Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.", "recall_initiation_date": "20191218", "center_classification_date": "20200129", "termination_date": "20221213", "report_date": "20200205", "code_info": "Lots: 61229:26 Use by: 03/25/2020; 61229:42 Use by: 03/25/2020"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0670-2020", "product_description": "BAC 2400MCG/ FENT 2600MCG/ MORP 3600MCG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12102019@2 Exp. 12/19/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0953-2020", "product_description": "Glutathione Injection,GLUTATHIONE 200MG/ML INJECTABLE  For IV, IM Use, Refrigerate, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-1231-3", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 10212019+53138, Exp 11/19/2020; 10302019+53172, Exp 1/28/2020; 11122019+53225, Exp 2/10/2020"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84516", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Natiowide", "recall_number": "D-0642-2020", "product_description": "Glenmark Ranitidine Tablets USP 300 mg Rx Only 100 Tablets Manufactured by: Glenmark Pharmaceuticals Ltd. Colvale-Bandez, Goa 403513, India   Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ   NDC 68462-249-01", "product_quantity": "1,309,536 bottles", "reason_for_recall": "CGMP Deviations: Presence of NDMA impurity detected in product.", "recall_initiation_date": "20191217", "center_classification_date": "20200105", "report_date": "20200115", "code_info": "7701030A  7701031A  7701062A  7701063A  7701110A  7701111A  7701112A  7701185A  7701186A  7701187A  7701188A  7701189A  7701269A  7701270A  7701278A  7701279A  7701386A  7701400A  7701401A  7701406A  7701421A  7701434A  7701435A  7701436A  7701452A  7701453A  7701521A  7701522B  7701553A  7701554A  7701555A  7701556A  7701582A  7701817A  7701828A  7701829A  7702001A  7702002A  7702003A  7702012A  7702026A  7702027A  7702064A  7702140A  7702253A  7702254A  7702285A  7702286A  7702287A  7702288A  7702294A  7702413A  7702462A  7702491A  7702492A  7702504A  7702505A  7702515A  7702698A  7702699A  7702700A  7702714A  7702719A  7702720A  7702747A  7702748A  7702749A  7702750A  7702751A  7702872A  7702873A  7702874A  7702917A  7702918A  7702919A  7702921A  7702922A  7702923A  7702945A  7703205A  7703410A  7703411A  7703412A  7703413A  7703414A  7703415A  7703451A  7703452A  7703453A  7703578A  7703579A  7703580A  7703581A  7703591A  7703592A  7703593A  7704372A  7704373A  7704374A  7704426A  7704427A  7704432A  7704463A  7704464A  7704465A  7704466A  7704508A  7704509A  7704510A  7704511A  7704512A  7704513A  7704563A  7704564A  7704746A  7704747A  7704748A  7704813A  7704841A  7704989A  7704990A  7705106A  7705320A  7705321A  7705322A  7705323A  7705324A  7705325A  7705326A  7705694A  7705703A  7705704A  7705702A  19190456  19190472  19190490  7701809A  7704862A  7704863A  7704864A  7704865A  7704866A  7704933A  7704934A"}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84527", "recalling_firm": "MPRX, Inc. dba Medical Park Pharmacy", "address_1": "8230 Elmbrook Dr Ste 600b", "address_2": "N/A", "postal_code": "75247-4144", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "TX", "recall_number": "D-0810-2020", "product_description": "Naltrexone 4.5 mg capsule", "product_quantity": "2 bottles", "reason_for_recall": "Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.", "recall_initiation_date": "20191218", "center_classification_date": "20200129", "termination_date": "20221213", "report_date": "20200205", "code_info": "Lot: 60564:42 Use by: 02/10/2020"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0711-2020", "product_description": "BUP 5.3MG/ FENT 1050 MCG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lots: 12112019@5 Exp. 12/20/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0936-2020", "product_description": "Alprostadil (prostaglandin E1) 80 MCG/ML Injectable, For Intracavernosal Use, Freeze, 2.5 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0543-2", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 11112019+53208, Exp 4/29/2020"}, {"country": "United States", "city": "Allegan", "address_1": "515 Eastern Ave", "reason_for_recall": "CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.", "address_2": "", "product_quantity": "", "code_info": "Lots: 8CE1643,   8DE1370,   8DE1768,   8EE1560,   8FE1452,   8GE1341,   8HE1223,   8KE2832,   8KE2246,   8ME2725,   9AE2835,   9CE3378,   9DE2748,   9EE2637,   9FE2976,   9GE2795,   9GE3228,   9HE3617", "center_classification_date": "20200313", "distribution_pattern": "Nationwide USA", "state": "MI", "product_description": "Regular Strength Acid Reducer, Ranitidine tablets, USP 75 mg, 80 tablets per bottle. [NDC: Brand] NDC Basic Care: 0113-7876-27; NDC CVS Health: 69842-293-27; NDC Leader: 70000-0375-2;  NDC Up & Up: 11673-876-27; NDC  Walgreens: 0363-1876-27", "report_date": "20200325", "classification": "Class II", "openfda": {}, "recalling_firm": "Perrigo Company PLC", "recall_number": "D-1014-2020", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "84127", "termination_date": "20201106", "more_code_info": "", "recall_initiation_date": "20191023", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0691-2020", "product_description": "BUP 20MG/CLON 250MCG/FENT 7200MCG/ML  INJ in 20 mL syringe Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12172019@5 Exp. 12/26/2019", "more_code_info": ""}, {"status": "Terminated", "city": "El Paso", "state": "TX", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "84620", "recalling_firm": "Idelle Labs", "address_1": "One Helen Of Troy Plaza", "address_2": "N/A", "postal_code": "79912", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0783-2020", "product_description": "SURE 48 hr Confidence Unscented invisible solid Anti-Perspirant & Deodorant, Net Wt. 2.6 oz (73g) NDC# 41595-5509-2 UPC 8 83484 71717 2 Made in Canada and Distributed by Idelle Labs, Ltd., El Paso, TX 79912", "product_quantity": "Unknown", "reason_for_recall": "Labeling Product Contains Undeclared API: Active Ingredient on label is not the active ingredient in the product.", "recall_initiation_date": "20191120", "center_classification_date": "20200116", "termination_date": "20220928", "report_date": "20200115", "code_info": "Lots: 19273K1, 19274K1, 19274K2, 19725K1, 19725K2, 19726K1"}, {"country": "United States", "city": "Morgantown", "address_1": "781 Chestnut Ridge Rd", "reason_for_recall": "CGMP Deviations: Trace amounts of an impurity, N-nitrosodimethylamine (NDMA) was detected in the API Nizatidine.", "address_2": "", "product_quantity": "31,736 bottles of 60 capsules", "code_info": "Lot Number: 3086746, exp. date May 2020", "center_classification_date": "20200120", "distribution_pattern": "Product was distributed to wholesalers, distributors , retail pharmacies, charitable organizations and mail order pharmacies throughout the United States and the product may have been further distributed.", "state": "WV", "product_description": "Nizatidine Capsules, USP 150 mg, Rx Only, Mylan Pharmaceuticals Inc., NDC 0378-5150-91.", "report_date": "20200129", "classification": "Class II", "openfda": {}, "recalling_firm": "Mylan Pharmaceuticals Inc.", "recall_number": "D-0791-2020", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "84607", "termination_date": "20210519", "more_code_info": "", "recall_initiation_date": "20200107", "postal_code": "26505-2730", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0713-2020", "product_description": "BUP 5MG/HYDROM 5MG/ML   INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lots: 12122019@26 Exp. 12/21/2019", "more_code_info": ""}, {"status": "Terminated", "city": "South Beloit", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85039", "recalling_firm": "Precision Dose Inc.", "address_1": "722 Progressive Ln", "address_2": "", "postal_code": "61080-2616", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-1004-2020", "product_description": "Ranitidine Oral Solution, USP, 150 mg/10 mL, [10 mL x 30 Unit Dose Cups per case, NDC: 68094-204-62; 10 mL x 100 Unit Dose Cups per case, NDC: 68094-204-61; Unit Dose Cup NDC: 68094-204-59], Rx only, Precision Dose, Inc., South Beloit, IL 61080", "product_quantity": "224,940 unit dose cups", "reason_for_recall": "CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API.", "recall_initiation_date": "20191113", "center_classification_date": "20200312", "termination_date": "20220917", "report_date": "20200318", "code_info": "Lot number: 501290, Expiry: 11/30/19, NDC: 68094-204-61;   Lot number: 501326, Expiry: 11/30/19, NDC: 68094-204-62;    Lot number: 501501, Expiry: 11/30/19, NDC: 68094-204-62;   Lot number: 1592, Expiry: 4/30/20, NDC: 68094-204-62;   Lot number: 501679, Expiry: 4/30/20, NDC: 68094-204-61, 68094-204-62", "more_code_info": ""}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0955-2020", "product_description": "Glycine Injection,GLYCINE USP  50MG/ML  INJECTABLE, For IV, IM Use,30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0344-3", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 07012019+52572, Exp 4/6/2020; 10102019+53106, Exp 6/30/2020"}, {"status": "Terminated", "city": "Chestnut Ridge", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA040584"], "brand_name": ["PREDNISONE"], "generic_name": ["PREDNISONE"], "manufacturer_name": ["Endo USA, Inc."], "product_ndc": ["0603-5335", "0603-5336", "0603-5337", "0603-5338", "0603-5339"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PREDNISONE"], "rxcui": ["198144", "198145", "198146", "312615", "312617", "763179", "763181", "763183", "763185"], "spl_id": ["e6628b5c-a3e4-462b-a01a-695ed8d3ab64"], "spl_set_id": ["10fe5a3b-84dc-4600-87c2-b80c97ce18cf"], "package_ndc": ["0603-5335-21", "0603-5335-32", "0603-5336-21", "0603-5337-21", "0603-5337-32", "0603-5337-15", "0603-5337-31", "0603-5338-21", "0603-5338-28", "0603-5338-32", "0603-5338-15", "0603-5338-31", "0603-5339-21", "0603-5339-28", "0603-5339-32"], "is_original_packager": [true], "upc": ["0306035335217", "0306035339215", "0306035338218"], "nui": ["N0000175576", "N0000175450"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "unii": ["VB0R961HZT"]}, "product_type": "Drugs", "event_id": "85136", "recalling_firm": "Par Pharmaceutical Inc.", "address_1": "1 Ram Ridge Rd", "address_2": "", "postal_code": "10977-6714", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-1035-2020", "product_description": "PrediniSONE Tablets, USP 5 mg, 48-count bottle,  Rx only, Distributed by: Par Pharmaceutical Chestnut Ridge, NY 10977,  NDC 0603-5337-31", "product_quantity": "13008 bottles", "reason_for_recall": "Labeling: Incorrect or Missing Exp Date - An incorrect expiration date has been identified on Prednisone Tablets USP 5 mg", "recall_initiation_date": "20200304", "center_classification_date": "20200318", "termination_date": "20210409", "report_date": "20200325", "code_info": "Lot #: 8672518, Exp 12/21", "more_code_info": ""}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0965-2020", "product_description": "Methionine/Inositol/Choline Injection, METHIONINE/INOSITOL/CHOLINE 25MG/50MG/50MG/ML INJECTABLE, For IM Use, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0215-3", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 09052019+52881, Exp 4/7/2020; 09302019+52977, Exp 5/2/2020; 10072019+53049, Exp 5/9/2020"}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0991-2020", "product_description": "Triamcinolone Diacetate Injectable Suspension, TRIAMCINOLONE DIACETATE [10ML] CMC 80 MG/ML INJ SUSP, For IM, IA, IT Use, 10 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0634-1", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 07162019+52686, Exp 4/11/2020; 11062019+53192, Exp 8/2/2020"}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0975-2020", "product_description": "MIC-PLUS Injection, Vitamin Complex, MIC-COMBO* 25MG/50MG/50MG/1MG/20MG/5MG/ML INJECTABLE, For IM Use, Refrigerate, Protect From Light, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0231-3", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 06242019+52513, Exp 1/23/2020; 06242019+52515, Exp 1/23/2020; 07252019+52756, Exp 2/23/2020; 08212019+52823, Exp 3/21/2020; 10012019+52989, Exp 5/1/2020; 11062019+53194, Exp 6/6/2020"}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84527", "recalling_firm": "MPRX, Inc. dba Medical Park Pharmacy", "address_1": "8230 Elmbrook Dr Ste 600b", "address_2": "N/A", "postal_code": "75247-4144", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "TX", "recall_number": "D-0805-2020", "product_description": "Lidocaine/Priloc/PE 15/5/0.25% 30 GM jars", "product_quantity": "2 jars", "reason_for_recall": "Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.", "recall_initiation_date": "20191218", "center_classification_date": "20200129", "termination_date": "20221213", "report_date": "20200205", "code_info": "Lot: 61367:42 Use by: 04/28/2020"}, {"status": "Ongoing", "city": "Qutbullapur Mandal, Ranga Redd", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA210243"], "brand_name": ["RANITIDINE"], "generic_name": ["RANITIDINE"], "manufacturer_name": ["Granules India Ltd"], "product_ndc": ["62207-773", "62207-774"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["RANITIDINE HYDROCHLORIDE"], "rxcui": ["198191"], "spl_id": ["262a80d3-d60c-b3c0-e063-6394a90a2705"], "spl_set_id": ["aab81d9f-397d-49fb-8083-77a1872cc71f"], "package_ndc": ["62207-774-58", "62207-774-41", "62207-774-47", "62207-774-36", "62207-773-58", "62207-773-41", "62207-773-47", "62207-773-32", "62207-773-36"], "is_original_packager": [true], "unii": ["BK76465IHM"]}, "product_type": "Drugs", "event_id": "84522", "recalling_firm": "Granules India Limited", "address_1": "Plot No. 160/A, 161/E, 162 and 174/A", "address_2": "Gagillapur Village", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "OR, NY, NJ", "recall_number": "D-0632-2020", "product_description": "RANITIDINE TABLETS, USP 150mg, 10,000-count bag, Country of Origin: INDIA  NDC 62207-773-32", "product_quantity": "23,090,000 tablets", "reason_for_recall": "CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API", "recall_initiation_date": "20191213", "center_classification_date": "20191229", "report_date": "20200108", "code_info": "7730001A, 7730002A, 7730003A, 7730004A, 7730005A, 7730006A, 7730007A, 7730008A, 7730009A, 7730010A, 7730011A and 7730012A"}, {"country": "United States", "city": "Glasgow", "address_1": "120 Carroll Knicely Dr", "reason_for_recall": "Failed Impurities/Degradation Specification: High Out of Specification Results for Individual Unknown Impurity.", "address_2": "", "product_quantity": "6929 blister cards", "code_info": "Lot #: 8170-9004, Exp 01/2020", "center_classification_date": "20200218", "distribution_pattern": "Nationwide in the USA.", "state": "KY", "product_description": "Glycopyrrolate Tabs, USP, 1 mg, 30-count unit dose blister card, FOR INSTITUTIONAL USE ONLY, Rx Only, Packaged by Vangard, Glasgow, KY 42141;  NDC 0615-8170-39.", "report_date": "20200226", "classification": "Class II", "openfda": {}, "recalling_firm": "NCS Healthcare of Kentucky Inc", "recall_number": "D-0850-2020", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "84992", "termination_date": "20210219", "more_code_info": "", "recall_initiation_date": "20200128", "postal_code": "42141-7224", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0934-2020", "product_description": "Alprostadil/Papaverine Hydrochloride/Phentolamine Mesylate/Atropine Sulfate Injection, 60 mcg/30 mg/2 mg/0.15mg/ml, For Intracavernosal Use, Freeze, 2.5 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0550-2", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 12042019+53323, Exp 1/17/2020"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0704-2020", "product_description": "BUP 35MG/MORP 10MG/ML  INJ in 20 mL syringe Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12162019@18 Exp. 12/25/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0962-2020", "product_description": "Lidocaine HCL (PF) Injection, LIDOCAINE HCL 4% (PF)  40 MG/ML INJECTABLE, For ocular injection, Preservative free, discard unused portion, protect from light, 5 mL Single-use Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-1011-5", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 07012019+52569, Exp 3/15/2020"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0682-2020", "product_description": "BUP 10MG/HYDROM 15MG/SUF 200MCG/ML  INJ in 20 mL syringe Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12162019@4 Exp. 12/25/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Hawthorne", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA040521"], "brand_name": ["PHENYTOIN"], "generic_name": ["PHENYTOIN"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["51672-4069"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PHENYTOIN"], "rxcui": ["1313112"], "spl_id": ["3cbd8a0c-6cfb-e0dd-e063-6394a90a8a26"], "spl_set_id": ["093fd736-5971-47af-b4ef-08c1696cebe8"], "package_ndc": ["51672-4069-1", "51672-4069-2"], "is_original_packager": [true], "upc": ["0351672406929"], "nui": ["N0000175753", "N0000008486", "N0000191266", "N0000187064", "N0000187063", "N0000185607", "N0000191267", "N0000190118", "N0000185507"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C8 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2D6 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]"], "unii": ["6158TKW0C5"]}, "product_type": "Drugs", "event_id": "84916", "recalling_firm": "Taro Pharmaceuticals U.S.A., Inc.", "address_1": "3 Skyline Dr", "address_2": "N/A", "postal_code": "10532-2174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA.", "recall_number": "D-0863-2020", "product_description": "Phenytoin Oral Suspension USP, 125 mg/5 mL potency,  8 fl oz (237 mL) Rx Only Mfd. by: Taro Pharmaceuticals Industries Ltd. Haifa Bay, Israel 2624761 Dist. by: Taro Pharmaceuticals U.S.A. Inc. Hawthorne, NY 10532,  NDC 51672-4069-1", "product_quantity": "29,172 8 Fl Oz bottles", "reason_for_recall": "Resuspension Problems: Two lots of Phenytoin Oral Suspension USP 125mg/5mL may coagulate and may not resuspend as per the label copy instructions.", "recall_initiation_date": "20200207", "center_classification_date": "20200302", "termination_date": "20231211", "report_date": "20200304", "code_info": "Lot# 327874, 327876, Exp Dec/2020"}, {"status": "Terminated", "city": "North Blenheim", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84657", "recalling_firm": "Denton Pharma, Inc.", "address_1": "119 Creamery Rd", "address_2": "", "postal_code": "12131-1613", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0794-2020", "product_description": "Ranitidine Tablets, USP 150 mg , a). 4 count bottle (NDC 70934-017-04), b). 20-count bottle (NDC 70934-017-20), c). 24-count bottle (NDC 70934-017-24) d). 30-count bottle (NDC 70934-017-30) e). 90-count bottle (NDC 70934-017-90), Rx Only, Repackaged by: Northwind Pharmaceuticals North Brenheim, NY 12131.", "product_quantity": "1,341 bottles", "reason_for_recall": "CGMP Deviations: Presence of NDMA impurity detected in product.", "recall_initiation_date": "20191220", "center_classification_date": "20200120", "termination_date": "20231005", "report_date": "20200129", "code_info": "a). N102851902, Exp. 04/30/2021    b). D102851801, Exp. 04/2021    c). N102851901, Exp. 11/30/2021       N102851903, Exp. 12/31/2021       N102851906, Exp. 03/31/2022    d). N102851904, Exp. 02/28/2022       N102851905, Exp. 12/31/2021    e). C102851901, Exp. 11/30/2021       C102851902, Exp. 11/30/2021       C102851903, Exp. 11/30/2021       C102851904, Exp. 05/31/2021       C102851905, Exp. 02/28/2022       C102851906, Exp. 02/28/2022       C102851907, Exp. 03/31/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0736-2020", "product_description": "HCG  3000U/1ML INJ in 4 mL vial Assurance Infusion (713)533-8800", "product_quantity": "2 vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lots: 11272019@31 Exp. 12/31/2019; 12022019@19 Exp. 01/05/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0990-2020", "product_description": "Triamcinolone Diacetate Injectable Suspension, TRIAMCINOLONE DIACETATE (PF) [2ML] CMC 40 MG/ML INJ SUSP, For IM, IA, IT Use, 2 mL Single Use Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0628-2", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 08272019+52845, Exp 2/23/2020; 09252019+52965, Exp 3/23/2020"}, {"status": "Terminated", "city": "Grover Beach", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84637", "recalling_firm": "H J Harkins Company Inc dba Pharma Pac", "address_1": "1400 W Grand Ave Ste F", "address_2": "", "postal_code": "93433-4221", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Distributed to Physicians in the following states: CA, FL, NC, and SC.", "recall_number": "D-0793-2020", "product_description": "Ranitidine, 150 mg Tablets, a) 7 count, b) 14 count, c) 20 count, d) 30 count, e) 60 count; Rx, Only, H.J. Harkins Company, Inc. dba Pharma Pac  Grover Beach, CA 93433 NDC #s: 52959-0502-07, 52959-0502-14, 52959-0502-20, 52959-0502-30 and 52959-0502-60", "product_quantity": "7,212 tablets", "reason_for_recall": "CGMP Deviations: Presence of NDMA impurity detected in product.", "recall_initiation_date": "20200106", "center_classification_date": "20200120", "termination_date": "20231215", "report_date": "20200129", "code_info": "Lot #s: RAN63KG   Exp. 05/20, RAN64KG   Exp. 10/20, RAN65KG   Exp. 11/20, RAN66KG   Exp. 05/21", "more_code_info": ""}, {"country": "United States", "city": "Allegan", "address_1": "515 Eastern Ave", "reason_for_recall": "CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.", "address_2": "", "product_quantity": "", "code_info": "Lots: 8AE1744,   8BE1369,   8CE1377,   8CE1378,   8DE1103,   8DE1531,   8EE1700,   8FV0829,   8DE1722,   8EE1317,   8FE1635,   8GE1921,   8HE1342,   8KE2503R,   8JE2154,   8KE2503,   8LE2198,   8LE2597,   9AE2499,   9BE2862,   9BE2863,   9CE3723,   9DE2890,   9DE2891,   9EE2812,   9FE3187,   9GE2885,   9HE3435,   9JE2656", "center_classification_date": "20200313", "distribution_pattern": "Nationwide USA", "state": "MI", "product_description": "Maximum Strength Acid Reducer, Ranitidine tablets, USP 150 mg, 50 tablets per bottle. [Brand, NDC] NDC DG Health: 55910-852-71; NDC Good Neighbor Pharmacy: 46122-224-71; NDC Good Sense: 0113-0852-71; NDC Harris Teeter: 69256-041-71; NDC Kroger: 30142-600-71; NDC Major: 0904-6716-51; NDC Meijer: 41250-852-71; NDC Publix: 56062-099-71; NDC Rite Aid: 11822-0852-2; NDC Signature Care: 21130-116-71; NDC Topcare: 36800-852-71", "report_date": "20200325", "classification": "Class II", "openfda": {}, "recalling_firm": "Perrigo Company PLC", "recall_number": "D-1021-2020", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "84127", "termination_date": "20201106", "more_code_info": "", "recall_initiation_date": "20191023", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Morgantown", "address_1": "781 Chestnut Ridge Rd", "reason_for_recall": "Presence of particulate matter. presence of metal particles.", "address_2": "", "product_quantity": "300 100-count bottles", "code_info": "Lot # 3095754, exp. date 02/2021", "center_classification_date": "20200318", "distribution_pattern": "Distributed Nationwide in the USA", "state": "WV", "product_description": "Sotalol HCL Tablets, USP (AF) 80 mg, 100 count bottles, Rx Only, Mylan Pharmaceuticals Inc. Morgantown, WV 26505 USA. NDC 00378-5123-01", "report_date": "20200325", "classification": "Class II", "openfda": {}, "recalling_firm": "Mylan Pharmaceuticals Inc.", "recall_number": "D-1031-2020", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "85152", "termination_date": "20210526", "more_code_info": "", "recall_initiation_date": "20200309", "postal_code": "26505-2730", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0985-2020", "product_description": "Testosterone Cypionate/Progesterone Injection, TESTOSTERONE CYP/PROGESTERONE [2ML] 200MG/2.5MG/ML INJECTABLE, For IM Use, 2 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0531-2", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 03042019+51685, Exp 6/26/2020"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0695-2020", "product_description": "BUP 21MG/CLON 252MCG/MORP 20MG/ML  INJ in 20 mL syringe Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12182019@1 Exp. 12/27/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Cranbury", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA201720"], "brand_name": ["TESTOSTERONE CYPIONATE"], "generic_name": ["TESTOSTERONE CYPIONATE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["62756-015", "62756-017", "62756-016"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR"], "substance_name": ["TESTOSTERONE CYPIONATE"], "rxcui": ["835829", "835840", "2047882"], "spl_id": ["bf24bb84-d12f-44e7-98bd-46f3aa792bcc"], "spl_set_id": ["3653a602-4551-4e6c-84a7-31861f5dc482"], "package_ndc": ["62756-017-40", "62756-015-40", "62756-016-40"], "is_original_packager": [true], "upc": ["0362756017405", "0362756015401", "0362756016408"], "unii": ["M0XW1UBI14"]}, "product_type": "Drugs", "event_id": "84672", "recalling_firm": "Sun Pharmaceutical Industries, Inc.", "address_1": "270 Prospect Plains Rd", "address_2": "", "postal_code": "08512-3605", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed throughout the United States.", "recall_number": "D-0787-2020", "product_description": "Testosterone Cypionate for Injection, USP, 1,000 mg/10 mL (100 mg/mL), 10 mL Multiple Dose Vial (NDC 62756-017-40), Rx only, Distributed by: Sun Pharmaceuticals, Inc., Cranbury, NJ, Manufactured by: Sun Pharmaceuticals, Industries, Ltd., Gujarat, India", "product_quantity": "", "reason_for_recall": "cGMP Deviations; released lots were manufactured under similar manufacturing conditions to a previously rejected OOS Lot.", "recall_initiation_date": "20200114", "center_classification_date": "20200116", "termination_date": "20200831", "report_date": "20200122", "code_info": "JKT0933A, JKT0935A, JKT1062A exp Mar-20;  JKT1425A, JKT1483A exp Apr-20;  JKT1575A, JKT1729A, JKT1730A, JKT1728A exp May-20  JKT2002A exp Jun-20;  JKT3216A, JKT3217A exp Sep-20;  JKT3589A, JKT3590A, JKT3626A exp Oct-20;  JKT3864A, JKT3935A exp Dec-20", "more_code_info": ""}, {"status": "Terminated", "city": "Pickerel", "state": "", "country": "Canada", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "84265", "recalling_firm": "Med Man Distribution, Inc.", "address_1": "433 Pickerel River Rd", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1037-2020", "product_description": "Bow & Arrow, Dietary Supplement, Libido Enhancer for Men, a) Four pack, b) Ten pack capsules per carton, Exclusively Manufactured by: Medicine Man Distribution, 4234 I-75 Business Spur, Sault Ste Marie, MI 49783", "product_quantity": "1880 cartons", "reason_for_recall": "Marketed without an Approved NDA/ANDA: Product contains undeclared sildenafil which was discovered through FDA analysis.", "recall_initiation_date": "20191108", "center_classification_date": "20200319", "termination_date": "20231017", "report_date": "20200325", "code_info": "All lots", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0729-2020", "product_description": "FENTANYL 1000MCG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12182019@3 Exp. 12/27/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Hastings", "state": "NE", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85081", "recalling_firm": "Redline Pharmacy Solutions", "address_1": "2415 Osborne Dr E Ste 100", "address_2": "", "postal_code": "68901-1999", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Sold to patients in Nebraska", "recall_number": "D-1008-2020", "product_description": "Daptomycin, 500MG in 0.9% NACL 100ML Injectable  Redline Specialty Pharmacy, 2415 Osborne Drive E, #100 Hastings, NE 68901", "product_quantity": "16 doses", "reason_for_recall": "Lack Of Processing Controls", "recall_initiation_date": "20200224", "center_classification_date": "20200312", "termination_date": "20220331", "report_date": "20200318", "code_info": "Lots 02242020@3, 02242020@9", "more_code_info": ""}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0935-2020", "product_description": "Alprostadil (prostaglandin E1)150 MCG/ML Injectable, For Intracavernosal Use, Freeze, 2.5 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0538-2", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 12042019+53331, Exp 1/17/2020"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0770-2020", "product_description": "TESTOSTERONE CYP 200MG/ML OIL in 10 mL vial  Assurance Infusion (713) 533-8800", "product_quantity": "5 vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 10242019@7 Exp. 04/21/2020; 10032019@11 Exp. 03/31/2020; 11042019@12 Exp. 05/02/2020; 09242019@9 Exp. 03/22/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84527", "recalling_firm": "MPRX, Inc. dba Medical Park Pharmacy", "address_1": "8230 Elmbrook Dr Ste 600b", "address_2": "N/A", "postal_code": "75247-4144", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "TX", "recall_number": "D-0806-2020", "product_description": "Lidocaine/Priloc/PE 30/5/0.25% 30 GM jars", "product_quantity": "12 jars", "reason_for_recall": "Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.", "recall_initiation_date": "20191218", "center_classification_date": "20200129", "termination_date": "20221213", "report_date": "20200205", "code_info": "Lots: 61134:42 Use by: 01/31/2020; 61302:26 Use by: 04/14/2020; 61318:42 Use by: 04/19/2020"}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84527", "recalling_firm": "MPRX, Inc. dba Medical Park Pharmacy", "address_1": "8230 Elmbrook Dr Ste 600b", "address_2": "N/A", "postal_code": "75247-4144", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "TX", "recall_number": "D-0815-2020", "product_description": "Sildenafil 80 mg capsules", "product_quantity": "1 bottle", "reason_for_recall": "Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.", "recall_initiation_date": "20191218", "center_classification_date": "20200129", "termination_date": "20221213", "report_date": "20200205", "code_info": "Lot: 61404:42 Use by: 05/06/2020"}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "84495", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "Harborplace Tower", "address_2": "111 S Calvert St Fl 21st", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-0635-2020", "product_description": "Bimatoprost Ophthalmic Solution, 0.03%, For Use in the Eyes Only, Sterile, Rx Only, 7.5 mL bottle, Manufactured by: Lupin Limited, Pithampur (M.P.), INDIA, NDC: 68180-429-03.", "product_quantity": "2,130 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out-of-specification result observed in any other individual impurity.", "recall_initiation_date": "20191213", "center_classification_date": "20200102", "termination_date": "20201019", "report_date": "20200108", "code_info": "Lot# H801686, Exp. 12/31/2019."}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0754-2020", "product_description": "MORPHINE 1MG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12122019@31 Exp. 12/21/2019; 12172019@8 Exp. 12/26/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84127", "recalling_firm": "Perrigo Company PLC", "address_1": "515 Eastern Ave", "address_2": "", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA", "recall_number": "D-1012-2020", "product_description": "Regular Strength Acid Reducer, Ranitidine tablets, USP 75 mg, 30 tablets per bottle. [NDC: Brand] NDC CVS Health: 69842-293-65; NDC Equaline 41163-931-65; NDC Family Wellness: 55319-876-65; NDC Good Sense 0113-0876-65; NDC H.E.B.: 37808-876-65; NDC Harris Teeter: 69256-876-65; NDC Health Mart: 62011-0283-1; NDC Leader: 62011-0283-1; NDC Major: 0904-6715-46; NDC Signature Care: 21130-118-65; NDC Sunmark: 49348-136-44; NDC Up & Up: 11673-876-65; NDC Walgreens: 0363-1876-65", "product_quantity": "", "reason_for_recall": "CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.", "recall_initiation_date": "20191023", "center_classification_date": "20200313", "termination_date": "20201106", "report_date": "20200325", "code_info": "Lots: 8DE1363,   8EE1558,   8FE1450,   8GE1331,   8HE1221,   8KE2825,   8JE1916,   8KE2243,   8ME2685,   9AE2785,   9AE2786,   9DE2721,   9CE3317,   9EE2579,   9FE2957,   9GE2785,   9GE3218,   9HE3577", "more_code_info": ""}, {"status": "Terminated", "city": "Cherry Hill", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA202691"], "brand_name": ["METHYLPREDNISOLONE SODIUM SUCCINATE"], "generic_name": ["METHYLPREDNISOLONE SODIUM SUCCINATE"], "manufacturer_name": ["Hikma Pharmaceuticals USA Inc."], "product_ndc": ["0143-9850", "0143-9851"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["METHYLPREDNISOLONE SODIUM SUCCINATE"], "rxcui": ["314099"], "spl_id": ["833d62b5-a589-4ea8-ad41-82d08d2d4589"], "spl_set_id": ["2e540674-0915-4498-8e2b-751c7e97532a"], "package_ndc": ["0143-9850-01", "0143-9851-01"], "is_original_packager": [true], "unii": ["LEC9GKY20K"]}, "product_type": "Drugs", "event_id": "84676", "recalling_firm": "Hikma Pharmaceuticals USA Inc.", "address_1": "2 Esterbrook Ln", "address_2": "", "postal_code": "08003-4002", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0801-2020", "product_description": "methylPREDNISolone Sodium Succinate For Injection, USP, 500 mg*/vial, Rx Only, Mfd by: HIKMA FARMACEUTICA (PORTUGAL), SA; Dist by: WEST-WARD, Eatontown, NJ 07724, NDC 0143-9850-01.", "product_quantity": "4840 vials", "reason_for_recall": "Labeling: Incorrect Instructions: Vial label incorrectly instructs healthcare professional to reconstitute product with 16 mL rather than the correct volume of 8 mL of Bacteriostatic Water for Injection with Benzyl Alcohol.", "recall_initiation_date": "20200114", "center_classification_date": "20200123", "termination_date": "20210908", "report_date": "20200129", "code_info": "Lot #: 1901113.1, Exp JUL 2021", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0719-2020", "product_description": "BUP 9MG/ HYDROM 25MG/ SUF 110MCG/ML  INJ in 20 mL syringe Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lots: 12172019@13 Exp. 12/26/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0766-2020", "product_description": "QUADMIX FORTE 30MG/4MG/40MCG/400MCG/ML INJ in 1 mL vial Assurance Infusion (713) 533-8800", "product_quantity": "134 vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lots: 07222019@10 Exp. 01/18/2020; 06242019@19 Exp. 12/21/2019; 08132019@15 Exp. 02/09/2020; 10292019@22 Exp. 04/26/2020; 11272019@24 Exp. 01/22/2020; 09182019@18 Exp. 03/16/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84527", "recalling_firm": "MPRX, Inc. dba Medical Park Pharmacy", "address_1": "8230 Elmbrook Dr Ste 600b", "address_2": "N/A", "postal_code": "75247-4144", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "TX", "recall_number": "D-0813-2020", "product_description": "Progesterone E4M SR 100 mg capsules", "product_quantity": "3 bottles", "reason_for_recall": "Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.", "recall_initiation_date": "20191218", "center_classification_date": "20200129", "termination_date": "20221213", "report_date": "20200205", "code_info": "Lot: 61219:42 Use by: 03/24/2020"}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85070", "recalling_firm": "American Health Packaging", "address_1": "2550 John Glenn Ave Ste A", "address_2": "", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-1003-2020", "product_description": "Ranitidine Tablets, USP, 150 mg, 100 Tablets (10 tablets x 10 blister card), Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217.  NDC carton: 60687-322-01; NDC Unit Dose Card: 60687-322-11", "product_quantity": "53,619 cartons", "reason_for_recall": "CGMP Deviations: Potential N-Nitrosodimethylamine (NDMA) amounts above levels established by the FDA.", "recall_initiation_date": "20191120", "center_classification_date": "20200312", "termination_date": "20220804", "report_date": "20200318", "code_info": "Lot, expiry:  Lots  179516, 179745, exp 12/31/2019; Lot 180712, exp 02/29/2020; Lot 180819, exp 04/30/2020; Lots 181403, 182544, 183155, 183236, exp 05/31/2020; Lots 185739, 186600, 186702, exp 12/31/2020", "more_code_info": ""}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["BLA022458"], "brand_name": ["ELELYSO"], "generic_name": ["TALIGLUCERASE ALFA"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "product_ndc": ["0069-0106"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["TALIGLUCERASE ALFA"], "rxcui": ["1292879", "1292881"], "spl_id": ["9e5fbf74-2937-46bd-bfaa-b8aab9386998"], "spl_set_id": ["fa3cbd5d-677c-4b19-9032-d9182cb69a83"], "package_ndc": ["0069-0106-01"], "is_original_packager": [true], "nui": ["N0000175820", "M0009360"], "pharm_class_epc": ["Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]"], "pharm_class_cs": ["Glucosylceramidase [CS]"], "unii": ["0R4NLX88O4"]}, "product_type": "Drugs", "event_id": "85067", "recalling_firm": "Pfizer Inc.", "address_1": "235 E 42nd St", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States and Albania, Israel, Serbia, Macedonia, Afghanistan, Botswana/South Africa/Zimbabwe, India, Israel, Rwanda, Uruguay, Mongolia", "recall_number": "D-0995-2020", "product_description": "Elelyso (taliglucerase alfa) for injection, 200 units/vials,, Rx only, Distributed by Pfizer Labs, Division of Pfizer Inc, NY, NY 10017.  NDC 0069-0106-01", "product_quantity": "24,714 vials", "reason_for_recall": "Lack of Assurance of Sterility--Reports of loose metal ferrule crimps on vials for injection. The entire cap either lifted or dislodged while attempting to flip off the orange color plastic button.", "recall_initiation_date": "20200227", "center_classification_date": "20200305", "termination_date": "20221228", "report_date": "20200311", "code_info": "Lot #:  X14209, Exp. Date 02/2020; AH4601, Exp. Date 03/2020; AH4603, X46389, X78365, AT2927, Exp. Date 04/2020; AH4602, Exp. Date 05/2020;  AL8590, Exp. Date 10/2020"}, {"status": "Terminated", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA078895"], "brand_name": ["CLONIDINE HYDROCHLORIDE"], "generic_name": ["CLONIDINE HYDROCHLORIDE"], "manufacturer_name": ["Unichem Pharmaceuticals (USA), Inc."], "product_ndc": ["29300-135", "29300-468", "29300-136", "29300-137"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CLONIDINE HYDROCHLORIDE"], "rxcui": ["884173", "884185", "884189"], "spl_id": ["5929c96f-9fa9-4399-84aa-28584da9966a"], "spl_set_id": ["21bfa28f-20df-43fd-bb80-b720d3b40696"], "package_ndc": ["29300-468-05", "29300-468-10", "29300-468-50", "29300-468-01", "29300-136-01", "29300-136-05", "29300-136-10", "29300-136-50", "29300-137-01", "29300-137-05", "29300-137-10", "29300-137-25", "29300-135-01", "29300-135-05", "29300-135-10", "29300-135-50"], "is_original_packager": [true], "upc": ["0329300136012", "0329300135015", "0329300468014", "0329300137019"], "unii": ["W76I6XXF06"]}, "product_type": "Drugs", "event_id": "84836", "recalling_firm": "UNICHEM PHARMACEUTICALS USA INC", "address_1": "1 Tower Center Blvd Ste 2200", "address_2": "N/A", "postal_code": "08816-1145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the US", "recall_number": "D-0829-2020", "product_description": "Clonidine Hydrochloride Tablets, USP 0.1mg, Rx Only, 100-count bottle, Manufactured by: Unichem Laboratories Ltd. Pilerne Ind. Estate, Pilerne Bardez, Goa 403 511 India. Manufactured for: Unichem Pharmaceuticals (USA), Inc. East Brunswick, NJ 08816.  NDC 29300-135-01", "product_quantity": "19161600 units", "reason_for_recall": "Failed Impurities/Degredation Specifications: This recall is initiated as a precautionary measure due to potential migration of Benzophenone at very low level into product from container label.", "recall_initiation_date": "20200129", "center_classification_date": "20200206", "termination_date": "20210108", "report_date": "20200212", "code_info": "Lot Numbers: GCLL18108, GCLL18109, GCLL18110 - EXP 10/31/2020; GCLL19003 EXP 12/31/2020"}, {"status": "Terminated", "city": "Gardena", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84799", "recalling_firm": "Spectrum Laboratory Products", "address_1": "14422 S San Pedro St", "address_2": "N/A", "postal_code": "90248-2027", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "The recalled API was distributed to pharmacies in the following states: AZ, CA, FL, GA, NJ, PA, RI, SC, TX, UT, WY. The API was also distributed internationally to Canada and UAE.", "recall_number": "D-0825-2020", "product_description": "Ranitidine Hydrochloride (powder), USP, Rx only, Spectrum Chemical Mfg Corp., a) 1 gram, b) 5 grams, c) 25 grams, d)100 grams, e) 500 grams, f) 1 Kilogram", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Presence of NDMA impurity detected in product.", "recall_initiation_date": "20200114", "center_classification_date": "20200204", "termination_date": "20231205", "report_date": "20200212", "code_info": "Lot #:11E0585, Exp. October 2023"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0738-2020", "product_description": "HYDROM 17MG/PRIALT 5MCG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12112019@12 Exp. 12/20/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0958-2020", "product_description": "Hydroxyprogesterone Caproate Injection, HYDROXYPROGESTERONE CAPROATE [4ML] 250 MG/ML INJECTABLE, For IV, IM Use, Refrigerate, 4 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0532-5", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 07302019+52772, Exp 2/25/2020"}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84527", "recalling_firm": "MPRX, Inc. dba Medical Park Pharmacy", "address_1": "8230 Elmbrook Dr Ste 600b", "address_2": "N/A", "postal_code": "75247-4144", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "TX", "recall_number": "D-0820-2020", "product_description": "Testosterone Topical Cream 4%", "product_quantity": "3 bottles", "reason_for_recall": "Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.", "recall_initiation_date": "20191218", "center_classification_date": "20200129", "termination_date": "20221213", "report_date": "20200205", "code_info": "Lot: 61463:42 Use by: 02/27/2020"}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0956-2020", "product_description": "Human Chorionic Gonadotropin (hCG) Injection, HCG [10ML] 1000 IU/ML INJECTABLE, For IM, SC Use, Refrigerate,10 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0533-1", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 07222019+52720, Exp 1/28/2020; 09182019+52923, Exp 3/26/2020; 10232019+53148, Exp 2/28/2020; 11142019+53243, Exp 5/22/2020"}, {"country": "United States", "city": "Cranbury", "address_1": "270 Prospect Plains Rd", "reason_for_recall": "Failed Impurities/Degradation Specifications; out-of-specification results obtained for related substance.", "address_2": "", "product_quantity": "207,585 blisters", "code_info": "JKT4174A, exp. date 11/2021  JKU0622A, exp. date 01/2022  JKU1308A, exp. date 02/2022", "center_classification_date": "20200113", "distribution_pattern": "Product was distributed throughout the United States to 96 distributors and 1 repacker/relabeler.", "state": "NJ", "product_description": "Sumatriptan Succinate Tablets, 100 mg  packaged in 9 (1X9) Unit-of-use blister card, (62756-0522-69), Rx only, Sun Pharma, Cranbury, NJ", "report_date": "20200122", "classification": "Class II", "openfda": {}, "recalling_firm": "Sun Pharmaceutical Industries, Inc.", "recall_number": "D-0660-2020", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "84570", "termination_date": "20201022", "more_code_info": "", "recall_initiation_date": "20191226", "postal_code": "08512-3605", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021514"], "brand_name": ["DAYTRANA"], "generic_name": ["METHYLPHENIDATE"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-5552", "68968-5553", "68968-5554", "68968-5555"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["METHYLPHENIDATE"], "rxcui": ["753436", "753437", "753438", "753439", "753440", "753441", "753442", "753443"], "spl_id": ["55f4b5f4-6d3c-4677-a94c-d47ffb59a91a"], "spl_set_id": ["2c312c31-3198-4775-91ab-294e0b4b9e7f"], "package_ndc": ["68968-5552-3", "68968-5553-3", "68968-5554-3", "68968-5555-3"], "is_original_packager": [true], "nui": ["N0000175739", "N0000175729"], "pharm_class_epc": ["Central Nervous System Stimulant [EPC]"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]"], "unii": ["207ZZ9QZ49"]}, "product_type": "Drugs", "event_id": "85128", "recalling_firm": "Noven Therapeutics, LLC", "address_1": "11960 Sw 144th St", "address_2": "", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-1044-2020", "product_description": "Daytrana (methylphenidate transdermal system) patches, Delivers 20 mg over 9 hours (2.2 mg/hr), 30-count box, Rx only, Manufactured for Noven Therapeutics, LLC. Miami, FL 33186, NDC 68968-5554-3", "product_quantity": "11093 boxes", "reason_for_recall": "Defective Delivery System: Out of specification for mechanical peel and shear.", "recall_initiation_date": "20200302", "center_classification_date": "20200319", "termination_date": "20230518", "report_date": "20200325", "code_info": "Lo#t: 86081, Exp 04/2020; 86196, Exp 06/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0675-2020", "product_description": "BAC 800MCG/BUP 6.7MG/CLON 600 MCG/FENT 850MCG/MORP 20MG   INJ in 20 mL syringe Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12162019@2 Exp. 12/25/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0676-2020", "product_description": "BACLOFEN 2000MCG/ML (40)  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "2 syringes", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12112019@18 Exp. 12/20/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "84526", "recalling_firm": "Motto International Corp", "address_1": "1908 Royal Ln Ste 700", "address_2": "", "postal_code": "75229-0269", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "TX", "recall_number": "D-0654-2020", "product_description": "Bull Platinum 30000 Capsules, 1000 mg, in orange, white, yellow background with silver text, packaged in 2, 4 and 10 count blister cards, Motto International, Dallas, TX", "product_quantity": "8 boxes", "reason_for_recall": "Marketed without an Approved NDA/ANDA; FDA analysis found product to contain tadalfil", "recall_initiation_date": "20191217", "center_classification_date": "20200110", "termination_date": "20211029", "report_date": "20200122", "code_info": "All lots remaining within expiry.", "more_code_info": ""}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0938-2020", "product_description": "Alprostadil/Papaverine Hydrochloride/Phentolamine Mesylate Injection  40MCG/30MG/2MG/ML Injectable, For Intracavernosal Use, Freeze, 2.5 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0546-2", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 11112019+53214, Exp 3/5/2020"}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0945-2020", "product_description": "Biotin (Vitamin H) Injectable Suspension, BIOTIN 10 MG/ML INJ SUSP, For IM Use, Refrigerate, Shake Well, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0220-3", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 11132019+53229, Exp 2/10/2020"}, {"country": "United States", "city": "Allegan", "address_1": "515 Eastern Ave", "reason_for_recall": "CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.", "address_2": "", "product_quantity": "", "code_info": "Lots: 8BE1032,   8BE1486,   8CE1638,   8DE1361,   8DE1612,   8FE1354,   8GE1737,   8HE1654,   8JE2237,   8KE2726,   8LE2369,   8ME2645,   9AE2777,   9CE3315,   9DE2720,   9EE2578,   9FE2956,   9GE2698,   9GE3202", "center_classification_date": "20200313", "distribution_pattern": "Nationwide USA", "state": "MI", "product_description": "Maximum Strength Acid Reducer, Cool Mint Ranitidine tablets, USP 150 mg, 95 tablets per bottle. [Brand, NDC] NDC Basic Care: 0113-7950-01; NDC CVS Health: 59779-950-01", "report_date": "20200325", "classification": "Class II", "openfda": {}, "recalling_firm": "Perrigo Company PLC", "recall_number": "D-1027-2020", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "84127", "termination_date": "20201106", "more_code_info": "", "recall_initiation_date": "20191023", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Allegan", "address_1": "515 Eastern Ave", "reason_for_recall": "CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.", "address_2": "", "product_quantity": "", "code_info": "Lots:  8EE1452R,   8AE1743,   8BE1340,   8CE1549,   8CE1778,   8DE1128,   8DE1313,   8DE1640,   8EE1117,   8EE1234,   8EE1452,   8CE1314,   8CE1315,   8DE1096,   8DE1530,   8EE1699,   8GE1528,   8HE1465,   8JE2199,   8LE2172,   8DE1721,   8EE1299,   8FE1634,   8GE1833,   8GE1835,   8HE1337,   8LE2173,   8LE2380,   9BE2888,   8JE2162,   8KE2495,   8KE2496,   8LE2169,   9BE2772,   9BE2889,   9CE3771,   9DE2854,   8LE2288,   8LE2592,   8LE2593,   8ME3124,   8ME3125,   9BE2773,   9BE2774,   9DE3234,   9EE2603,   9EE2903,   9FE2952,   9CE3689,   9CE3690,   9EV1891,   9FV1152,   9DE2868,   9DE2869,   9EE2760,   9FV1153,   9EE2779,   9GE2879,   9HE3558,   9JE2591,   9FE3109,   9FE3110,   9GE2869,   9HE3433,   9JE2541", "center_classification_date": "20200313", "distribution_pattern": "Nationwide USA", "state": "MI", "product_description": "Maximum Strength Acid Reducer, Ranitidine tablets, USP 150 mg, 24 tablets per bottle. [Brand, NDC] NDC Being Well: 46994-852-62; NDC Care One 41520-392-02; NDC CVS Health: 59779-540-02; NDC DG Health: 55910-852-02; NDC Equaline: 41163-852-62; NDC Equate: 49035-608-02; NDC Exchange Select: 55301-852-02; NDC Family Wellness: 55319-852-02; NDC Good Neighbor Pharmacy: 46122-224-62; NDC Good Sense 0113-0852-62; NDC Harris Teeter: 69256-041-62; NDC Health Mart 49348-109-04; NDC Kroger 30142-600-02; NDC Major 0904-6716-24; NDC Meijer: 41250-852-02; NDC Publix: 56062-099-02; NDC Rite Aid 11822-0852-5; NDC Select 7: 10202-852-62; NDC Shop Rite 41190-852-62; NDC Shopko: 37012-852-62; NDC Signature Care: 21130-116-02; NDC Sound Body: 50594-852-02; NDC Sunmark: 62011-0282-1; NDC Topcare: 36800-852-02; NDC Up & Up: 11673-023-02; NDC Walgreens: 0363-0852-62", "report_date": "20200325", "classification": "Class II", "openfda": {}, "recalling_firm": "Perrigo Company PLC", "recall_number": "D-1018-2020", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "84127", "termination_date": "20201106", "more_code_info": "", "recall_initiation_date": "20191023", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84990", "recalling_firm": "American Health Packaging", "address_1": "2550 John Glenn Ave Ste A", "address_2": "", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0848-2020", "product_description": "Desmopressin Acetate Tablets, 0.1 mg, 30 tablets (3 x 10 unit dose blister cards), Rx Only, Packaged and distributed by:  American Health Packaging, Columbus, Ohio 43217.  NDC Carton: 68084-606-21; NDC Unit Dose 68084-606-11", "product_quantity": "1,879 cartons", "reason_for_recall": "GMP Deviations: Product bottle may be absent of desiccant.", "recall_initiation_date": "20200207", "center_classification_date": "20200218", "termination_date": "20220804", "report_date": "20200226", "code_info": "Lot 181109, exp 4/30/2020", "more_code_info": ""}, {"country": "United States", "city": "Lake Forest", "address_1": "150 N Field Dr Ste 350", "reason_for_recall": "Subpotent Drug", "address_2": "", "product_quantity": "864 bags", "code_info": "Lot #s:   193040035S, Exp. 12/29/2019;   193120031S, Exp. 01/08/2020;  193150024S, Exp. 01/09/20;  193180030S, Exp. 01/12/20;  193240028S, Exp. 01/18/20;  193250022S, Exp. 01/19/20.", "center_classification_date": "20191223", "distribution_pattern": "Nationwide in the U.S.", "state": "IL", "product_description": "NORepinephrine Bitartrate 8 mg added to 500 mL 5% Dextrose Injection USP (16 mcg per mL) Total Volume 508.00 mL Viaflex Bag, High Alert, Rx Only, PharMEDium Services LLC., 12620 W Airport Blvd #130 Sugar Land, TX 77478.", "report_date": "20200101", "classification": "Class III", "openfda": {}, "recalling_firm": "Pharmedium Services, LLC", "recall_number": "D-0626-2020", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "84525", "termination_date": "20210209", "more_code_info": "", "recall_initiation_date": "20191216", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84261", "recalling_firm": "Akorn, Inc.", "address_1": "1925 W Field Ct Ste 300", "address_2": "N/A", "postal_code": "60045-4862", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0647-2020", "product_description": "MYORISAN (isotretinoin capsules, USP), 20mg, packaged in 30-count Capsules (3 x 10 Prescription Packs) per box, Rx only, Distributed by:  VersaPharm Inc. - An Akorn Company, Lake Forset, IL 60045; NDC 61748-302-13.", "product_quantity": "4,206 boxes", "reason_for_recall": "Unit Dose Mispackaging: Customer complaint that a carton labeled as Myorisan 20 mg Capsules, USP erroneously contained one 10-count blister card of the 40 mg product in addition to two 10-count blister cards of the 20 mg product.", "recall_initiation_date": "20191115", "center_classification_date": "20200106", "termination_date": "20220809", "report_date": "20200108", "code_info": "Lot V20M54A, Exp 01/2021"}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0966-2020", "product_description": "Methylcobalamin Injection, METHYLCOBALAMIN [CD] 10MG/100MG/ML INJECTABLE, For IV, IM, SC Use, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0338-3", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 07292019+52764, Exp 1/25/2020; 07292019+52766, Exp 1/25/2020"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0671-2020", "product_description": "BAC 250MCG/ /FENT 3500MCG/ /MORP 25MG/ML  INJ in 20 mL syringe Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12172019@6 Exp. 12/26/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0777-2020", "product_description": "TRIMIX FORTE 4 (UA) 30MG/3MG/30MCG/ML INJ in 1 mL vial Assurance Infusion (713) 533-8800", "product_quantity": "10 vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 08302019@4 Exp. 02/26/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0741-2020", "product_description": "HYDROMORPHONE 1MG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12122019@9 Exp. 12/21/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0748-2020", "product_description": "IPAMORELIN 2000MCG/ML  INJ in 2 mL vial  Assurance Infusion (713) 533-8800", "product_quantity": "5 vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lots: 07162019@20 Exp. 01/12/2020; 12102019@17 Exp. 06/07/2020; 07162019@20 Exp. 01/12/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Piscataway", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84610", "recalling_firm": "Appco Pharma LLC", "address_1": "262 Old New Brunswick Rd Unit N", "address_2": "N/A", "postal_code": "08854-3756", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product was distributed to 6 major distributors/wholesalers some with multiple locations who may have further distribute the product.", "recall_number": "D-0648-2020", "product_description": "Ranitidine Capsules 300 mg, 30 count bottles. Rx only, Manufactured by: Appco Pharma LLC, Piscataway, NJ 08854, Distributed by: ANI Pharmaceuticals, Inc., Baudette, MN 56623, NDC 62559-691-30.", "product_quantity": "1,632 bottes", "reason_for_recall": "CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API", "recall_initiation_date": "20200107", "center_classification_date": "20200107", "termination_date": "20200424", "report_date": "20200115", "code_info": "Batch #   1905227UE, exp. date Apr-2021  1905228UE, exp. date Apr-2021"}, {"status": "Terminated", "city": "Hastings", "state": "NE", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85081", "recalling_firm": "Redline Pharmacy Solutions", "address_1": "2415 Osborne Dr E Ste 100", "address_2": "", "postal_code": "68901-1999", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Sold to patients in Nebraska", "recall_number": "D-1007-2020", "product_description": "Morphine Sulfate, 20 mg/mL intrathecal, 20 mL per syringe.  Redline Specialty Pharmacy, 2415 Osborne Drive E, #100 Hastings, NE 68901", "product_quantity": "1 20 ml syringe", "reason_for_recall": "Lack Of Processing Controls", "recall_initiation_date": "20200224", "center_classification_date": "20200312", "termination_date": "20220331", "report_date": "20200318", "code_info": "Lot 02242020@2", "more_code_info": ""}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84527", "recalling_firm": "MPRX, Inc. dba Medical Park Pharmacy", "address_1": "8230 Elmbrook Dr Ste 600b", "address_2": "N/A", "postal_code": "75247-4144", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "TX", "recall_number": "D-0804-2020", "product_description": "Finasteride/Biotin 1 mg/50 mcg", "product_quantity": "1 bottle", "reason_for_recall": "Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.", "recall_initiation_date": "20191218", "center_classification_date": "20200129", "termination_date": "20221213", "report_date": "20200205", "code_info": "Lot: 60658:42 Use by: 12/28/2019"}]